The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle-invasive bladder cancer.
 
Alexandre R. Zlotta
Stock and Other Ownership Interests - iTP Biomedica
Honoraria - mIR Scientific; Theralase; Verity Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; BioSyent; Ferring; Merck; mIR Scientific; Sanofi; Theralase; Verity Pharmaceuticals
Research Funding - AstraZeneca (Inst); Ferring (Inst); Merck (Inst); Sanofi (Inst); Verity Pharmaceuticals (Inst)
 
Leslie K. Ballas
Employment - University of Southern California Keck School of Medicine
 
Andrzej Niemierko
No Relationships to Disclose
 
Katherine Lajkosz
No Relationships to Disclose
 
Cynthia Kuk
No Relationships to Disclose
 
Gus Miranda
No Relationships to Disclose
 
Michael Drumm
No Relationships to Disclose
 
Andrea Mari
Consulting or Advisory Role - Sanofi
 
Neil E. Fleshner
Leadership - POINT Biopharma
Stock and Other Ownership Interests - Verity Pharmaceuticals
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Sanofi (Inst); Spectracure (Inst)
 
Girish S. Kulkarni
Honoraria - Abbvie; BioSyent; Tersera
Consulting or Advisory Role - Ferring; Janssen Oncology; Merck; Theralase
 
Peter W. M. Chung
Honoraria - Abbvie; AstraZeneca; Boston Scientific
Consulting or Advisory Role - Tersera; Verity Pharmaceuticals
Research Funding - Abbvie
 
Robert G. Bristow
No Relationships to Disclose
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seattle Genetics (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)
 
Adam S. Feldman
Honoraria - Janssen
Consulting or Advisory Role - Olympus; Vessi Medical
Research Funding - Convergent Genomics (Inst)
 
Matthew Wszolek
No Relationships to Disclose
 
Richard J. Lee
Consulting or Advisory Role - Bayer; Bayer; Dendreon; exelixis; Exelixis; GE Healthcare; Janssen Oncology; Janssen Oncology; Noxopharm; Tolero Pharmaceuticals
Research Funding - Janssen
 
Anthony L. Zietman
Leadership - Elsevier
 
William U. Shipley
No Relationships to Disclose
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bristol-Myers Squibb; Ferring; Janssen; Johnson & Johnson; Nucleix; Olympus; pacific edge; Photocure; QED Therapeutics; Seattle Genetics; Spectrum Pharmaceuticals
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Jason A. Efstathiou
Consulting or Advisory Role - AstraZeneca; Blue Earth Diagnostics; Boston Scientific; Merck; Myovant Sciences; Roivant